Ginsenoside Rk1 mitigates type 2 diabetes mellitus by targeting signal transducer and activator of transcription 3 to alleviate adipocyte hypertrophy and adipose tissue inflammation in diabetic mice.
- DOI
- 10.1016/j.jare.2026.07.009
- Published
- 2026 Jul 3
- Container
- Journal of advanced research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jare.2026.07.009,
title = {Ginsenoside Rk1 mitigates type 2 diabetes mellitus by targeting signal transducer and activator of transcription 3 to alleviate adipocyte hypertrophy and adipose tissue inflammation in diabetic mice.},
author = {Vong CT and Tan D and Liu M and Zhou T and Gao C and Chen Z and Xu Y and Chen Z and Liao F and Ling Tseng HH and Li G and Cheang WS and Chong CM and Man Hoi MP and Wang S},
year = {2026},
journal = {Journal of advanced research},
doi = {10.1016/j.jare.2026.07.009},
url = {https://doi.org/10.1016/j.jare.2026.07.009}
}RIS
TY - JOUR TI - Ginsenoside Rk1 mitigates type 2 diabetes mellitus by targeting signal transducer and activator of transcription 3 to alleviate adipocyte hypertrophy and adipose tissue inflammation in diabetic mice. AU - Vong CT AU - Tan D AU - Liu M AU - Zhou T AU - Gao C AU - Chen Z AU - Xu Y AU - Chen Z AU - Liao F AU - Ling Tseng HH AU - Li G AU - Cheang WS AU - Chong CM AU - Man Hoi MP AU - Wang S PY - 2026 JO - Journal of advanced research DO - 10.1016/j.jare.2026.07.009 UR - https://doi.org/10.1016/j.jare.2026.07.009 ER -
APA
CT, V., D, T., M, L., T, Z., C, G., Z, C., Y, X., Z, C., F, L., HH, L. T., G, L., WS, C., CM, C., MP, M. H., & S, W. (2026). Ginsenoside Rk1 mitigates type 2 diabetes mellitus by targeting signal transducer and activator of transcription 3 to alleviate adipocyte hypertrophy and adipose tissue inflammation in diabetic mice.. Journal of advanced research. https://doi.org/10.1016/j.jare.2026.07.009
Source records
- pubmed · retrieved 2026-09-26T12:07:16.921Z